Overview

* Curaleaf Q2 2025 revenue falls 8% yr/yr

* Adjusted gross margin improves 120 basis points to 49% yr/yr

* International revenue grows 62% yr/yr, driven by robust demand

Outlook

* Company anticipates Turkey market launch in 2026

* Company aims to capitalize on emerging cannabis opportunities

Result Drivers

* DOMESTIC STABILIZATION - Curaleaf ( CURLF ) reports stabilization in domestic markets, contributing to sequential revenue growth

* INTERNATIONAL MOMENTUM - International revenue grew 62% yr/yr, driven by strong demand and expansion efforts

* EFFICIENCY IMPROVEMENTS - Adjusted gross margin increased 120 basis points due to improved cultivation and manufacturing efficiencies

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Total $315 mln

Revenue

Q2 Gross $152.55

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the pharmaceuticals peer group is "buy"

* Wall Street's median 12-month price target for Curaleaf Holdings Inc ( CURLF ) is C$4.00, about 34.8% above its August 5 closing price of C$2.61

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)